Trial NCT00085410

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-00046
Secondary IDs: 03-042 6135 CDR0000369715 NCI-2009-00046

Last trial update was posted on 2017-07-02

MeSH Interventions

Bortezomib

MeSH Conditions

Adenocarcinoma Bile Duct Neoplasms Cholangiocarcinoma Gallbladder Neoplasms Gastrointestinal Neoplasms Liver Neoplasms Recurrence

Other Conditions

Adenocarcinoma of the Extrahepatic Bile Duct Adenocarcinoma of the Gallbladder Advanced Adult Primary Liver Cancer Gastrointestinal Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Recurrent Extrahepatic Bile Duct Cancer Recurrent Gallbladder Cancer Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer

Stopping Reasons

The trial was discontinued early due to no confirmed partial responses.

Limitations And Caveats

The trial was discontinued early due to no confirmed partial responses.

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID